
What We’re Reading: UnitedHealth Sued Over Denied Claims; Alzheimer Drug Cost to Taxpayers; Maternity Care Access Worsens
The US Labor Department initiated a lawsuit against a UnitedHealth Group unit after it allegedly denied thousands of claims without assessing their merit; the cost of lecanemab, the first drug that claims to slow the advance of Alzheimer disease, will mostly fall upon taxpayers; nearly 7 million women in the US live in maternity care deserts with little to no access to maternal care.
US Labor Department Sues UnitedHealth Over Denied Claims
The US Labor Department initiated a lawsuit on Monday against a UnitedHealth Group unit alleging that it denied thousands of emergency department and drug screening claims without reviewing whether they were medically necessary, according to
New Alzheimer Drug Cost Falls Mostly on Taxpayers
Lecanemab (Leqembi), the first drug that appears to slow the advance of Alzheimer disease, may cost the US health care system billions annually despite the barriers to access for many lower-income seniors, according to
Access to Maternity Care in the US Continues to Worsen
Nearly 7 million women in the United States have little to no access to maternal care, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.